Neurologists should consider CSF1R-microglial encephalopathy when a patient exhibits early-onset rapid progressive dementia with symmetrical changes and persistent diffusion restriction in the deep white matter because the genetic spectrum of mutations is yet to be fully elucidated. This evidence concerns the gene CSF1R and dementia.